Location History:
- Umea, SE (2015)
- Umeå, SE (2013 - 2019)
Company Filing History:
Years Active: 2013-2019
Title: Innovator Gianna Ragagnin: Pioneering Treatments for CNS Disorders
Introduction
Gianna Ragagnin is a prominent inventor based in Umeå, Sweden, recognized for her impactful contributions to the field of pharmaceutical innovations. With a remarkable portfolio of four patents, she focuses on developing treatments for central nervous system (CNS) disorders, showcasing her dedication to enhancing human health through scientific advancements.
Latest Patents
Gianna Ragagnin's latest patents include significant advancements in pharmaceutical compounds. One of her key inventions is the development of 3α-ethynyl, 3β-hydroxy-5α-pregnan-20-oxime, which is designed for use in the treatment of CNS disorders. This compound, along with its pharmaceutically acceptable salts, acts as a modulator of brain excitability through the gamma-aminobutyric acid receptor-chloride ionophore (GABA-R) complex. It holds promise for treating conditions such as hepatic encephalopathy, Down's syndrome, and Alzheimer's disease.
In addition, she has innovated steroids with enhanced water solubility and increased resistance against metabolism. These steroid compounds, along with their production methods, are aimed at creating pharmaceuticals that can effectively treat steroid-related or steroid-induced CNS disorders, offering new avenues for prevention and alleviation.
Career Highlights
Throughout her career, Gianna has been associated with key organizations such as Umecrine Cognition AB and Umecrine AB. Her work in these companies has solidified her reputation as a leader in the development of pharmaceutical solutions targeting complex health issues, particularly those affecting the central nervous system.
Collaborations
Gianna's collaborative efforts have significantly enriched her research and development initiatives. She has worked alongside esteemed professionals like Torbjörn Bäckström, fostering a team dynamic that encourages innovation and problem-solving in the realm of CNS disorders.
Conclusion
Gianna Ragagnin continues to be a driving force in the field of pharmaceutical innovations, focusing on groundbreaking treatments for CNS disorders. Her inventive spirit and dedication to improving patient outcomes through her patents reflect her commitment to science and health, marking her as a noteworthy inventor in today's medical landscape.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.